Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

16.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.1K
Viral Mutations00:36

Viral Mutations

33.9K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
33.9K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

202
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
202
Genomics02:02

Genomics

37.8K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
37.8K
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

4.1K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.1K
Prevalence and Incidence01:08

Prevalence and Incidence

878
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
878

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From plastics to pathology: The neurodegenerative impact of Bisphenol-A on Alzheimer's disease.

Ageing research reviews·2026
Same author

In silico and in vitro antibacterial investigation of <i>Origanum majorana</i> L. leaves extract against gram-positive and gram-negative bacteria.

In silico pharmacology·2026
Same author

Barriers to Mainstream School Inclusion Among Children with Autism Spectrum Disorder.

Annals of neurosciences·2026
Same author

Pharmaco-Epigenomic response of Pimozide is mediated through miR-2909.

Integrative biology : quantitative biosciences from nano to macro·2026
Same author

Decoding neuroinflammation: the critical role of NLRP3 inflammasome in Alzheimer's disease.

Inflammopharmacology·2026
Same author

Evaluation of the neuroprotective effects of ergosterol in a streptozotocin-induced Alzheimer's disease rat model: Insights into anti-inflammatory and antioxidant mechanisms.

Experimental neurology·2026

Related Experiment Video

Updated: Sep 28, 2025

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.4K

Update on omicron variant: What we know so far.

Gajendra Choudhary1, Manisha Prajapat1, J Kumaravel1

  • 1Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Indian Journal of Pharmacology
|March 28, 2022
PubMed
Summary
This summary is machine-generated.

The Omicron variant of SARS-CoV-2 has numerous mutations, particularly in its spike protein, potentially reducing vaccine and antibody effectiveness. This highlights the need for booster doses and further research into its impact.

Keywords:
COVID-19HIVmutationsomicronsevere acute respiratory syndrome coronavirus 2variant

More Related Videos

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.4K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

2.9K

Related Experiment Videos

Last Updated: Sep 28, 2025

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.4K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.4K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

2.9K

Area of Science:

  • Virology
  • Immunology
  • Public Health

Background:

  • The emergence of the Omicron variant (B.1.1.529) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in November 2021.
  • Designation as a Variant of Concern by the World Health Organization due to significant mutations.

Purpose of the Study:

  • To analyze the mutations present in the Omicron variant.
  • To assess the impact of these mutations on existing SARS-CoV-2 interventions, including vaccines and neutralizing antibodies.
  • To discuss the implications for booster doses, infection severity, and potential links to immune-compromised individuals and HIV prevalence.

Main Methods:

  • Bioinformatic analysis of Omicron variant mutations.
  • Review of current scientific literature on SARS-CoV-2 variants and immune responses.
  • Comparative analysis of Omicron's mutation profile against previous variants.

Main Results:

  • The Omicron variant possesses a high number of mutations, many concentrated in the spike protein.
  • These mutations may confer increased immune escape from antibodies and vaccines.
  • Potential for increased reinfection rates and implications for therapeutic efficacy.

Conclusions:

  • The unique mutation profile of the Omicron variant necessitates a re-evaluation of current SARS-CoV-2 control strategies.
  • Booster doses are likely crucial to enhance protection against Omicron.
  • Further investigation is required to understand Omicron's transmissibility, severity, and the hypothesized link with immune-compromised populations and HIV prevalence.